Featured correspondence
LettersNovel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath
Correspondence to:
Correspondence to Dr S S Achanta, Rangaraya Medical College, Dno 69-3-33/2 us Rajucolony Gigolupadujn, Kakinada, India; achantasri@rediffmail.com
| The first 150 words of the full text of this article appear below. |
To the editor: It is known that emergency doctors misdiagnose heart failure in about 40% of cases and these patients have a high mortality rate of around 21%. The novel biomarkers such as the BNP assay significantly improve the accuracy of diagnosis of acute heart failure in patients presenting to the emergency department with dyspnoea.1 2 At the cut-off point of 100 pg/ml, BNP has a sensitivity of 90% but the specificity is only 73%. Even though this study showed that the addition of MR-proANP produces no clinically relevant increase in diagnostic accuracy, the combination of other biomarkers like MR ANP may significantly increase the diagnostic power in conditions such as renal dysfunction, obesity, and in the elderly and those with oedema, as B type peptides can cause some problems in these conditions. The BACH trial has clearly shown that the multimarker approach to the diagnosis of heart failure is
Relevant Article
- The authors reply:
- B Dieplinger, A Gegenhuber, M Haltmayer, and T Mueller
Heart 2009 95: 1627.[Extract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
